Cargando…

Inositols in Midlife

This review describes the mechanistic, animal, and clinical data related to the use of inositols in midlife. It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol and randomized controlled trials conducted in postmenopausal women with metabolic syndrome and suppor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Kalra, Bharti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879846/
https://www.ncbi.nlm.nih.gov/pubmed/29628727
http://dx.doi.org/10.4103/jmh.JMH_52_16
_version_ 1783311064049385472
author Kalra, Sanjay
Kalra, Bharti
author_facet Kalra, Sanjay
Kalra, Bharti
author_sort Kalra, Sanjay
collection PubMed
description This review describes the mechanistic, animal, and clinical data related to the use of inositols in midlife. It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol and randomized controlled trials conducted in postmenopausal women with metabolic syndrome and supports these data with the results of in vitro and animal studies on inositol in nephropathy and other related conditions. Recent advances related to biochemistry, pharmaceutical science, and genetics are discussed. It concludes that inositols have a potential role to play in maintaining metabolic health in postmenopausal women.
format Online
Article
Text
id pubmed-5879846
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58798462018-04-06 Inositols in Midlife Kalra, Sanjay Kalra, Bharti J Midlife Health Brief Communication This review describes the mechanistic, animal, and clinical data related to the use of inositols in midlife. It covers studies related to the mechanism of action of myo-inositol and D-chiro-inositol and randomized controlled trials conducted in postmenopausal women with metabolic syndrome and supports these data with the results of in vitro and animal studies on inositol in nephropathy and other related conditions. Recent advances related to biochemistry, pharmaceutical science, and genetics are discussed. It concludes that inositols have a potential role to play in maintaining metabolic health in postmenopausal women. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5879846/ /pubmed/29628727 http://dx.doi.org/10.4103/jmh.JMH_52_16 Text en Copyright: © 2018 Journal of Mid-life Health http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Brief Communication
Kalra, Sanjay
Kalra, Bharti
Inositols in Midlife
title Inositols in Midlife
title_full Inositols in Midlife
title_fullStr Inositols in Midlife
title_full_unstemmed Inositols in Midlife
title_short Inositols in Midlife
title_sort inositols in midlife
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879846/
https://www.ncbi.nlm.nih.gov/pubmed/29628727
http://dx.doi.org/10.4103/jmh.JMH_52_16
work_keys_str_mv AT kalrasanjay inositolsinmidlife
AT kalrabharti inositolsinmidlife